TITLE

Pharmacoeconomics of Influenza Vaccination for Healthy Working Adults: Reviewing the Available Evidence

AUTHOR(S)
Postma, M.J.; Jansema, P.; van Genugten, M.L.L.; Heijnen, M-L.A.; Jager, J.C.; de Jong-van den Berg, L.T.W.
PUB. DATE
April 2002
SOURCE
Drugs;2002, Vol. 62 Issue 7, p1013
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
A favourable pharmacoeconomic profile has been well established for influenza vaccination in the elderly. For employers relevant benefits seem to exist for vaccinating healthy working adults to avert absenteeism and related production losses. From a pharmacoeconomic point of view it is relevant to consider whether societal benefits of vaccination for healthy working adults is worthwhile given the costs of vaccination for the community. We searched Medline and Embase using the key words influenza (vaccination) in combination with cost, cost-benefit, cost-effectiveness, efficiency, economic evaluation, health-policy and pharmacoeconomics. From this primary search, we selected 11 studies concerned with the group of healthy working adults. We reviewed these studies according to several criteria: benefit-to-cost (B/C) ratio; vaccine effectiveness, influenza incidence, number of days of work absence due to illness; and relative cost of the vaccine. Three studies on vaccinating healthy working adults found costs exceeding the benefits (B/C-ratio <1). The remaining eight pharmacoeconomic studies found a B/C-ratio of almost two or more. Cost savings are strongly related to the inclusion of indirect benefits related to averted production losses. After exclusion of indirect costs and benefits of production gains/losses, only one of the eight studies remains cost saving. Considering the available pharmacoeconomic evidence, vaccination of healthy working adults in Western countries may be an intervention with favourable cost-effectiveness and cost-saving potentials if indirect benefits of averted production losses are included. Excluding indirect benefits and costs of production losses/gains, cost-saving potentials are limited. Recent international guidelines for pharmacoeconomic research advise the inclusion of production gains and losses in the preferred societal perspective. Hence, on the basis of the available evidence, influenza vaccination of healthy working adults may be recommended from pharmacoeconomic point of view. Pharmacoeconomics do, however, present only one argument for consideration aside from ethical issues, budgetary limits and psychosocial aspects.
ACCESSION #
6604888

 

Related Articles

  • The benefits of influenza immunisation. Cockcroft, Anne // BMJ: British Medical Journal (International Edition);07/19/97, Vol. 315 Issue 7101, p171 

    Focuses on the benefits of giving influenza immunization to employees. Reduction in level of sickness absence in the organization during winter months; Recommendation of routine influenza vaccination in the United States for group in contact with vulnerable patients.

  • Flu shots for the healthy. McSchulskis, Elaine // HR Magazine;Jan1997, Vol. 42 Issue 1, p26 

    Deals with the effect of flu vaccination on employee. Statistics on the absenteeism due to colds and flu among employees; Assessment of Vicky Dickson, CIGNA nurse practitioner, regarding the company-sponsored flu vaccination.

  • Flu vaccination at work can save money. Tucker, Charlotte // Nation's Health;Nov/Dec2011, Vol. 41 Issue 9, p16 

    The article discusses the findings of the Partnership for Prevention Report which reveals the economic benefits of conducting workplace flu vaccination programs for U.S. companies including improved worker attendance and productivity, and increased savings on health-related costs.

  • Planning influenza vaccination programs: a cost benefit model. Duncan, Ian G.; Taitel, Michael S.; Zhang; Kirkham, Heather S. // Cost Effectiveness & Resource Allocation;2012, Vol. 10 Issue 1, p10 

    Background: Although annual influenza vaccination could decrease the significant economic and humanistic burden of influenza in the United States, immunization rates are below recommended levels, and concerns remain whether immunization programs can be cost beneficial. The research objective was...

  • Mandatory flu vaccines.  // McKnight's Long-Term Care News;Mar2012, Vol. 33 Issue 3, p20 

    The article reports on a proposal made by the health department officials of Colorado for making flu vaccinations mandatory for all nursing home employees.

  • A Shot in the Arm to Help Fight the Flu. Harting, Don // Business Journal (Central New York);11/10/2000, Vol. 14 Issue 45, p1B 

    Focuses on the advantages of providing on-site influenza vaccines to employees in New York. Increase in the number of companies offering the benefit; Inclusion of the program in the corporate-wellness movement; Fear of litigation by some companies.

  • How Much Would it Cost To Inoculate My Employees? D. H. // Business Journal (Central New York);11/10/2000, Vol. 14 Issue 45, p3B 

    Focuses on the cost of providing influenza vaccines to employees in New York. Price of each shot; Options for offering the benefit; Examples of companies offering such services.

  • Manufacturing Delay Means It May Not Be Too Late To Get A Shot.  // Business Journal (Central New York);11/10/2000, Vol. 14 Issue 45, p4B 

    Reports the delay in the manufacture of influenza vaccines in the United States. Report from the US Centers for Disease Control and Prevention; Recommendation for the inoculation of high-risk employees first; List of vaccine providers.

  • IMPROVING INFLUENZA VACCINE COMPLIANCE AMONGST NURSING HOME EMPLOYEES: A MULTIDISCIPLINARY APPROACH. Jean-Jacques, L.; Wolf-Klein, G.; Silverstone, F. A. // Gerontologist;Oct1996 Supplement, Vol. 36 Issue 1, p237 

    To determine profiles of compliance with flu vaccination amongst health care providers, we surveyed the 775 day shift employees of a 527 bed long term care facility with over 1100 admissions per year. All staff were offered free vaccination during their work hours. Sixty-five percent of the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics